Strand, V., van Vollenhoven, R. F., Lee, E. B., Fleischmann, R., Zwillich, S. H., Gruben, D., . . . Wallenstein, G. (2016). Tofacitinib or adalimumab versus placebo: Patient-reported outcomes from a phase 3 study of active rheumatoid arthritis. Rheumatology (Oxford).

Strand, Vibeke, Ronald F. van Vollenhoven, Eun Bong Lee, Roy Fleischmann, Samuel H. Zwillich, David Gruben, Tamas Koncz, Bethanie Wilkinson, a Gene Wallenstein. "Tofacitinib or Adalimumab Versus Placebo: Patient-reported Outcomes From a Phase 3 Study of Active Rheumatoid Arthritis." Rheumatology (Oxford) 2016.

Strand, Vibeke, et al. "Tofacitinib or Adalimumab Versus Placebo: Patient-reported Outcomes From a Phase 3 Study of Active Rheumatoid Arthritis." Rheumatology (Oxford) 2016.